018742009

180 THERAPEUTICS

---

August 3, 2022

Trademark Summary

The trademark application 180 THERAPEUTICS was filed by 180 LIFE SCIENCES CORP., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 7, 2022, and it was registered by office on December 15, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Analgesic preparations
  2. Pharmaceutical preparations for the treatment of inflammatory diseases
  3. Pharmaceutical preparations for the treatment of inflammation
  4. Pharmaceutical preparations for the treatment of dupuytren's disease
  5. Pharmaceutical preparations for the treatment of frozen shoulder
  6. Pharmaceutical preparations for the treatment of post-operative delirium
  7. Pharmaceutical preparations for the treatment of post-operative cognitive deficit
  8. Pharmaceutical preparations for the treatment of post-operative cognitive decline
  9. Pharmaceutical preparations for the treatment of non-alcoholic steatohepatitis
  10. Pharmaceutical preparations for the treatment of fibrosis
  11. Pharmaceutical preparations for the treatment of liver fibrosis
  12. Pharmaceutical preparations for the treatment of arthritis
  13. Pharmaceutical preparations for the treatment of pain
  14. Pharmaceutical preparations for the treatment of ulcerative colitis
  15. Pharmaceutical preparations for the treatment of anxiety
  16. Pharmaceutical preparations for the treatment of type 1 diabetes
  17. Pharmaceutical preparations for the treatment of type 2 diabetes
  18. Pharmaceutical preparations for inhibition of tumor necrosis factor (tnf)
  19. Pharmaceutical preparations for interacting with nicotine receptors
  20. Pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (cbd)
  21. Pharmaceutical preparations for liver regeneration
  22. Pharmaceutical preparations for regenerative therapy
  23. Pharmaceutical preparations for acting as an alpha-7nachr agonist.
• The mark was filed in class 42 with following description of goods:
  
  1. Development of pharmaceutical preparations and medicines
  2. Pharmaceutical drug development services
  3. Pharmaceutical product evaluation
  4. Pharmaceutical research and development
  5. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
  6. Research and development in the pharmaceutical and biotechnology fields
  7. Scientific research for medical purposes in the field of inflammatory diseases
  8. Scientific research for medical purposes in the field of treatment of inflammation
  9. Scientific research for medical purposes in the field of dupuytren's disease
  10. Scientific research for medical purposes in the field of frozen shoulder
  11. Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline
  12. Scientific research for medical purposes in the field of non-alcoholic steatohepatitis
  13. Scientific research for medical purposes in the field of fibrosis
  14. Scientific research for medical purposes in the field of liver fibrosis
  15. Scientific research for medical purposes in the field of arthritis
  16. Scientific research for medical purposes in the field of pain treatment
  17. Scientific research for medical purposes in the field of ulcerative colitis
  18. Scientific research for medical purposes in the field of treatment of anxiety
  19. Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (tnf) and anti-tnf pharmaceuticals
  20. Scientific research for medical purposes in the field of interactions with nicotine receptors
  21. Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (cbd)
  22. Scientific research for medical purposes in the field of synthetic cannabidiol (cbd) analogs
  23. Scientific research for medical purposes in the field of type 1 diabetes
  24. Scientific research for medical purposes in the field of type 2 diabetes
  25. Scientific research for medical purposes in the field of liver regeneration
  26. Scientific research for medical purposes in the field of regenerative therapy
  27. Scientific research for medical purposes in the field of alpha-7nachr agonists.